BioCorp Clinical Laboratory has announced plans to bring its comprehensive medical testing services to cities across California, with more than 30 new locations set to open. These plans are made possible by the new influx of support from VR Corporation and RGS Armenia, BioCorp’s two newest investors.
As the largest insurance company in Armenia, RGS Armenia is uniquely positioned to provide the financial support and advice necessary for BioCorp’s infrastructure as the company continues to grow. Additional support from Los Angeles-based investment firm VR Corporation is poised to help BioCorp extend its reach throughout Southern California.
BioCorp has provided clinical reference laboratory services such as blood testing, testing for women’s health conditions and infectious diseases, and pathology testing since its launch in 2006. BioCorp uses the latest innovations in medical technology, such as mass spectrometry and molecular testing, as well as tried-and-true culture and stain techniques. The company has also provided COVID-19 testing since the pandemic started in 2020.
BioCorp currently has 10 locations in cities throughout the Greater Los Angeles area and elsewhere, including Glendale, Glendora, Rancho Cucamonga, and Bakersfield. As BioCorp sets its gaze toward the future, the laboratory hopes to open at least 50 more locations.